Loading...
Lifecore Biomedical, Inc.
LFCR•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$7.20
$0.07(0.98%)
U.S. Market opens in 13h 38mLifecore Biomedical, Inc. (LFCR) AI-Powered Stock Analysis
See how Lifecore Biomedical, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerLifecore Biomedical, Inc. (LFCR) Stock Overall Grade
Lifecore Biomedical, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Lifecore Biomedical, Inc.'s overall stock rating.
Forecast
C+Score
59/100Financial Growth
B+Score
70/100Fundamental Growth
C+Score
51/100Key Ratios
CScore
42/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
58/100Lifecore Biomedical, Inc. (LFCR) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 59/100 (C+), reflecting weak confidence in its potential. Financial Growth (70/100, B+) and Fundamental Growth (51/100, C+) highlight its stability, while Key Ratios (42/100, C) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (58/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Lifecore Biomedical, Inc. stock grade, including financials, comparisons, and forecasts.